Change in hepatitis C virus genotype in hemodialysis patients after end-of-treatment response to interferon monotherapy - Relapse or re-infection?

Journal of Medical Virology

Volumn 80, Issue 1, 2008, Pages 80-86

  Arrais, Teresa C ^a,f   Van Dooren, Sonia ^b   Vandamme, Anne Mieke ^b   Brechot, Christian ^c,d,e   Rimlinger, Francois ^c,d,e   Silva, Antonio Eduardo ^a   Perez, Renata M ^a   Ferraz, Maria Lucia G ^a   Thiers, Valerie ^c,d,e  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c INSTITUT PASTEUR   (France)

^d INSERM   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Genotype; HCV; Hemodialysis; Nosocomial transmission; NS5B region

Indexed keywords

INTERFERON; RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENOTYPE; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; MALE; MONOTHERAPY; NUCLEOTIDE SEQUENCE; PHYLOGENY; RELAPSE; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS STRAIN;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; PHYLOGENY; RECURRENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 36849065447     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21050     Document Type: Article

References (43)

1. Ansaldi F, Bruzzone B, de Florentiis D, Marasso P, Gota F, Mofferdin A, Campello C, Crovari P, Icardi G. 2003. An outbreak of hepatitis C virus in a haemodialysis unit: Molecular evidence of patient-to-patient transmission. Ann Ig 15:685-691.
2. Bracho MA, Gosalbes MJ, Blasco D, Moya A, Gonzalez-Candelas F. 2005. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit. J Clin Microbiol 43:2750-2755.
3. Carneiro MA, Teles SA, Lampe E, Espirito-Santo MP, Gouveia-Oliveira R, Reis NR, Yoshida CF, Martins RM. 2007. Molecular and epidemiological study on nosocomial transmission of HCV in hemodialysis patients in Brazil. J Med Virol 79:1325-1333.
4. Chen Z, Week KE. 2002. Hepatitis C virus genotyping: Interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol 40:3127-3134.
5. Covic A, Iancu L, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, Covic M. 1999. Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 14:40-45.
6. de Lamballerie X, Olmer M, Bouchouareb D, Zandotti C, de Micco P. 1996. Nosocomial transmission of hepatitis C virus in haemodialysis patients. J Med Virol 49:296-302.
7. Degos F, Pol S, Chaix ML, Laffitte V, Buffet C, Bernard PH, Degott C, Carnot F, Riffaud PC, Chevret S. 2001. The tolerance and efficacy of interferon-alpha in haemodialysis patients with HCV infection: A multicentre, prospective study. Nephrol Dial Transplant 16:1017-1023.
8. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Gonzalez R, Rodriguez M, Aljama P. 2002. Natural history of acute HCV infection in hemodialysis patients. Clin Nephrol 58:143-150.
9. Fabrizi F, Poordad FF, Martin P. 2002. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 36:3-10.
10. Fabrizi F, Bunnapradist S, Lunghi G, Martin P. 2003a. Kinetics of hepatitis C virus load during hemodialysis: Novel perspectives. J Nephrol 16:467-475.
11. Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P. 2003b. Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 18:1071-1081.
12. Fabrizi F, de Vecchi AF, Como G, Lunghi G, Martin P. 2005. De novo HCV infection among dialysis patients: A prospective study by HCV core antigen ELISA assay. Aliment Pharmacol Ther 21:861-869.
13. Furusyo N, Kubo N, Nakashima H, Kashiwagi K, Etoh Y, Hayashi J. 2004. Confirmation of nosocomial hepatitis C virus infection in a hemodialysis unit. Infect Control Hosp Epidemiol 25:584-590.
14. Gonzalez-Candelas F, Bracho MA, Moya A. 2003. Molecular epidemiology and forensic genetics: Application to a hepatitis C virus transmission event at a hemodialysis unit. J Infect Dis 187:352-358.
15. Herring BL, Page-Shafer K, Tobler LH, Delwart EL. 2004. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 190:1396-1403.
16. Hmaied F, Ben Mamou M, Saune-Sandres K, Rostaing L, Slim A, Arrouji Z, Ben Redjeb S, Izopet J. 2004. Hepatitis C virus infection among dialysis patients in Tunisia: Incidence and molecular evidence for nosocomial transmission. J Med Virol 78:185-191.
17. Huraib S, Al Rashed R, Aldrees A, Aljefry M, Arif M, al Faleh FA. 1995. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: A need for new dialysis strategies. Nephrol Dial Transplant 10:470-474.
18. Katsoulidou A, Paraskevis D, Kalapothaki V, Arvanitis D, Karayiannis P, Hadjiconstantiou V, Hatzakis A. 1999. Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 14:1188-1194.
19. Kokubo S, Horii T, Yonekawa O, Ozawa N, Mukaide M. 2002. A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit. J Viral Hepat 9:450-454.
20. Kumar S, Tamura K, Nei M. 2004. MEG A3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5:150-163.
21. Laperche S, Lunel F, Izopet J, Alain S, Deny P, Duverlie G, Gaudy C, Pawlotsky JM, Plantier JC, Pozzetto B, Thibault V, Tosetti F, Lefrere JJ. 2005. Comparison of hepatitis C virus NS5b and 5′ noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 43:733-739.
22. Lau JY, Davis GL, Prescott LE, Maertens G, Lindsay KL, Qian K, Mizokami M, Simmonds P. 1996. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 124:868-876.
23. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A. 1998. Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission. J Clin Microbiol 36:3040-3043.
24. MMWR. 2001. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50:1-43.
25. Moreira RC, Lemos MF, Longui CA, Granato C. 2005. Hepatitis C and hemodialysis: A review. Braz J Infect Dis 9:269-275.
26. NIH. 2002. Consensus Statement on Management of Hepatitis C. NIH Consens State Sci Statements 19:1-46.
27. Olmer M, Bouchouareb D, Zandotti C, de Micco P, de Lamballerie X. 1997. Transmission of the hepatitis C virus in an hemodialysis unit: Evidence for nosocomial infection. Clin Nephrol 47:263-270.
28. Page RD. 1996. TreeView: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 12:357-358.
29. Pol S, Vallet-Pichard A, Fontaine H, Lebray P. 2002. HCV infection and hemodialysis. Semin Nephrol 22:331-339.
30. Poordad FF, Fabrizi F, Martin P. 2004. Hepatitis C infection associated with renal disease and chronic renal failure. Semin Liver Dis 24:69-77.
31. Prati D. 2006. Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global review. J Hepatol 45:607-616.
32. Qian KP, Natov SN, Pereira BJ, Lau JY. 2000. Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat 7:153-160.
33. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T. 2005. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41:106-114.
34. Salama G, Rostaing L, Sandres K, Izopet J. 2000. Hepatitis C virus infection in French hemodialysis units: A multicenter study. J Med Virol 61:44-51.
35. Sanchez-Tapias JM. 1999. Nosocomial transmission of hepatitis C virus. J Hepatol 31:107-112.
36. Schroter M, Feucht HH, Zollner B, Schafer P, Laufs R. 2003. Multiple infections with different HCV genotypes: Prevalence and clinical impact. J Clin Virol 27:200-204.
37. Simmonds P. 2004. Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 85:3173-3188.
38. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin I, Stuyver L-J, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
39. Sypsa V, Psichogiou M, Katsoulidou A, Skoutelis G, Moutafis S, Hadjiconstantinou V, Kakavas J, Kalapothaki V, Boletis J, Hatzakis A. 2005. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 45:334-343.
40. Tamura K, Nei M, Kumar S. 2004. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA 101:11030-11035.
41. Tanaka M, Fujiyama S, Tanaka M, Itoh K, Matsushita K, Hara M, Kuwahara K, Yasumoto N, Nishimura Y, Yoshimura N, Tomita K. 2003. Examination of HCV infection in hemodialysis patients with HCV-RNA assay using a magnetic extraction method (AmpliCap GT HCV MONITOR Test Kit v2.0 and AmpliCap GT HCV Specimen Preparation Kit v2.0). Nippon Jinzo Gakkai Shi 45:91-97.
42. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876-4882.
43. Yves Van de Peer Y. 2003. Phylogeny inference based on distance methods. In: Salemi M, Vandamme A-M, editors. The Phylogenetic Handbook: A Practical Approach to DNA and Protein Phylogeny. Cambridge: Press Syndicate of the University of Cambridge, United Kingdom, pp 101-119.